These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36310212)

  • 1. CD and Solid-State NMR Studies of Low-Order Oligomers of Transthyretin.
    Dasari AKR; Lim KH
    Methods Mol Biol; 2023; 2551():311-320. PubMed ID: 36310212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers.
    Dasari AKR; Hughes RM; Wi S; Hung I; Gan Z; Kelly JW; Lim KH
    Sci Rep; 2019 Jan; 9(1):33. PubMed ID: 30631096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Characterization of Cardiac Ex Vivo Transthyretin Amyloid: Insight into the Transthyretin Misfolding Pathway In Vivo.
    Dasari AKR; Hung I; Michael B; Gan Z; Kelly JW; Connors LH; Griffin RG; Lim KH
    Biochemistry; 2020 May; 59(19):1800-1803. PubMed ID: 32338497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy.
    Lindgren M; Sörgjerd K; Hammarström P
    Biophys J; 2005 Jun; 88(6):4200-12. PubMed ID: 15764666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-State NMR Studies Reveal Native-like β-Sheet Structures in Transthyretin Amyloid.
    Lim KH; Dasari AK; Hung I; Gan Z; Kelly JW; Wright PE; Wemmer DE
    Biochemistry; 2016 Sep; 55(37):5272-8. PubMed ID: 27589034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic Misfolded Transthyretin Oligomers with Different Molecular Conformations Formed through Distinct Oligomerization Pathways.
    Dasari AKR; Yi S; Coats MF; Wi S; Lim KH
    Biochemistry; 2022 Nov; 61(21):2358-2365. PubMed ID: 36219173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transthyretin monomer intermediate undergoes local unfolding and transient interaction with oligomers in a kinetically concerted aggregation pathway.
    Sun X; Ferguson JA; Dyson HJ; Wright PE
    J Biol Chem; 2022 Aug; 298(8):102162. PubMed ID: 35724960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct aggregation pathways in transthyretin misfolding and amyloid formation.
    Dasari AKR; Hung I; Gan Z; Lim KH
    Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):344-349. PubMed ID: 30366153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.
    Lim KH; Dasari AKR; Ma R; Hung I; Gan Z; Kelly JW; Fitzgerald MC
    Biochemistry; 2017 Sep; 56(36):4808-4818. PubMed ID: 28820582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Changes Associated with Transthyretin Misfolding and Amyloid Formation Revealed by Solution and Solid-State NMR.
    Lim KH; Dasari AK; Hung I; Gan Z; Kelly JW; Wemmer DE
    Biochemistry; 2016 Apr; 55(13):1941-4. PubMed ID: 26998642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of α-synuclein oligomers formed in the presence of lipid vesicles.
    Dasari AKR; Sengupta U; Viverette E; Borgnia MJ; Kayed R; Lim KH
    Biochem Biophys Rep; 2024 Jul; 38():101687. PubMed ID: 38545462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the CD Loop by Enzymatic Cleavage Promotes the Formation of Toxic Transthyretin Oligomers through a Common Transthyretin Misfolding Pathway.
    Dasari AKR; Arreola J; Michael B; Griffin RG; Kelly JW; Lim KH
    Biochemistry; 2020 Jun; 59(25):2319-2327. PubMed ID: 32500705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational flexibility tunes the propensity of transthyretin to form fibrils through non-native intermediate states.
    Das JK; Mall SS; Bej A; Mukherjee S
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12781-4. PubMed ID: 25251500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of conformational dynamics in pathogenic protein aggregation.
    Sun X; Dyson HJ; Wright PE
    Curr Opin Chem Biol; 2023 Apr; 73():102280. PubMed ID: 36878172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of α-sheet in Amyloid Oligomer Aggregation and Toxicity.
    Bi TM; Daggett V
    Yale J Biol Med; 2018 Sep; 91(3):247-255. PubMed ID: 30258312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid formation by human carboxypeptidase D transthyretin-like domain under physiological conditions.
    Garcia-Pardo J; Graña-Montes R; Fernandez-Mendez M; Ruyra A; Roher N; Aviles FX; Lorenzo J; Ventura S
    J Biol Chem; 2014 Dec; 289(49):33783-96. PubMed ID: 25294878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Force spectroscopy reveals the presence of structurally modified dimers in transthyretin amyloid annular oligomers.
    Pires RH; Saraiva MJ; Damas AM; Kellermayer MS
    J Mol Recognit; 2017 Mar; 30(3):. PubMed ID: 27808434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Searching for the Best Transthyretin Aggregation Protocol to Study Amyloid Fibril Disruption.
    Ferreira E; Almeida ZL; Cruz PF; Silva E Sousa M; Veríssimo P; Brito RMM
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destabilization of transthyretin by pathogenic mutations in the DE loop.
    Takeuchi M; Mizuguchi M; Kouno T; Shinohara Y; Aizawa T; Demura M; Mori Y; Shinoda H; Kawano K
    Proteins; 2007 Feb; 66(3):716-25. PubMed ID: 17143887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases.
    Limbocker R; Cremades N; Cascella R; Tessier PM; Vendruscolo M; Chiti F
    Acc Chem Res; 2023 Jun; 56(12):1395-1405. PubMed ID: 37071750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.